RNAi Therapeutic definition

RNAi Therapeutic means any product that is based on or comprises at least one siRNA.
RNAi Therapeutic means a therapeutic product containing, comprised of or based on one or more siRNAs or siRNA derivatives or other moieties effective in gene function modulation and designed to modulate the function of particular genes or gene products through RNA interference.

Examples of RNAi Therapeutic in a sentence

  • During the Therapeutic Collaboration Term, MERCK shall provide to ALNYLAM a minimum of [**] MERCK Non-Druggable Targets which are candidates for RNAi Therapeutic Products during the first [**] of each of the first [**] years of the Therapeutic Collaboration Term, beginning with the year starting September 1, 2004, in accordance with the procedures set forth below.

  • After selecting a MERCK RNAi Novel Target, ALNYLAM shall use commercially reasonable efforts to develop an RNAi Therapeutic Product directed at such MERCK RNAi Novel Target.

  • The goal of the Therapeutic Collaboration is to develop RNAi Therapeutic Products for disease-associated targets which are not amenable to therapeutic intervention by conventional small molecule chemistry.

  • Notwithstanding the above, "Opt-In Information" shall include all information, materials and/or data listed on Schedule 2.14.3.2 which is in ALNYLAM's or its Affiliate's possession (either by ownership or license) and relating to the RNAi Therapeutic Product.

  • ALNYLAM shall fund and be responsible for conducting all research and development of MERCK RNAi Novel Targets for discovery and development of RNAi Therapeutic Products as set forth herein and in the workplan developed pursuant to Section 2.14.1 through the completion of IND-Enabling GLP Toxicology Studies, at which time MERCK may exercise its Opt-In Right as set forth below.

  • The Parties agree to conduct all their Development activities relating to the RNAi Therapeutic Products directed to Co-Development Targets in accordance with the applicable Program Workplan.

  • If more than one patent is eligible for extension or patent term restoration, the Parties shall agree upon a strategy that shall maximize patent protection and commercial value for RNAi Therapeutic Products.

  • To the extent required by law or permitted by law, the Parties shall use Commercially Reasonable Efforts to maintain with the applicable Regulatory Authorities during the Agreement Term correct and complete listings of applicable Patent Rights for the each Selected RNAi Therapeutic being Commercialized, including all so-called "Orange Book" listings required under the Xxxxx-Xxxxxx Act.

  • Biogen Idec shall have the right, but not the obligation, to defend any Infringement Claim brought against either Party or its Affiliates or Sublicensees arising out of the Discovery, Development, Manufacture or Commercialization of a Selected RNAi Therapeutic in the Territory; provided, however, that Alnylam shall defend any such Infringement Claim relating to Blocking RNAi Technology or Broad RNAi Technology Controlled by Alnylam if it so desires.

  • The Parties shall collaborate in carrying out the Therapeutic Collaboration with the objective of developing RNAi Therapeutic Products for Targets associated with human diseases.

Related to RNAi Therapeutic

  • Therapeutic diet means meals served that are soft, low-fat, low-sodium or controlled calorie.

  • Therapeutic school means a residential group living facility:

  • Vaccine means a specially prepared antigen which, upon administration to a person, will result in immunity and, specifically for the purposes of this rule, shall mean influenza and pneumococcal vaccines.

  • Formulation means the combination of various ingredients designed to render the product useful and effective for the purpose claimed, or the form of pesticide as purchased by users;

  • Diagnostic Product means In Vitro Diagnostics, In Vivo Diagnostic Agents and any product used for Diagnosis.

  • Gene Therapy means the introduction of a nucleic acid sequence encoding a protein intended for or otherwise conferring therapeutic benefit into a person for therapeutic purposes (i) by in vivo introduction for incorporation into cells of such person, or (ii) by ex vivo introduction into cells for transfer into a person.

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Diagnostic mammography means a method of screening that

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Therapeutic care means services provided by licensed or certified speech pathologists, Occupational Therapists and Physical Therapists.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Opioid antagonist means a drug that binds to opioid

  • Radiopharmaceutical means any drug that exhibits spontaneous disintegration of unstable nuclei with the emission of nuclear particles or photons and includes any non-radioactive reagent kit or radionuclide generator that is intended to be used in the preparation of any such substance, but does not include drugs such as carbon-containing compounds or potassium-containing salts that include trace quantities of naturally occurring radionuclides. The term also includes any biological product that is labeled with a radionuclide or intended solely to be labeled with a radionuclide.

  • Biological agent shall mean any pathogenic (disease producing) micro-organism(s) and/or biologically produced toxin(s) (including genetically modified organisms and chemically synthesized toxins) which cause illness and/or death in humans, animals or plants.

  • Medical marijuana product means a product that contains cannabinoids that have been extracted from plant material or the resin therefrom by physical or chemical means and is intended for administration to a licensed patient, including but not limited to concentrates, oils, tinctures, edibles, pills, topical forms, gels, creams, and other derivative forms, except that this term does not include live plant forms.

  • Therapeutically equivalent drug products means drug products that contain the same active ingredients and are identical in strength or concentration, dosage form, and route of administration and that are classified as being therapeutically equivalent by the U.S. Food and Drug Administration pursuant to the definition of "therapeutically equivalent drug products" set forth in the most recent edition of the Approved Drug Products with Therapeutic Equivalence Evaluations, otherwise known as the "Orange Book."

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Commercializing means to engage in Commercialization and “Commercialized” has a corresponding meaning.

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Therapeutic Equivalent means that a Covered Drug can be expected to produce essentially the same therapeutic outcome and toxicity.

  • in vitro diagnostic medical device means any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information:

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Step therapy protocol means a protocol or program that establishes the specific

  • Dose is a generic term that means absorbed dose, dose equivalent, effective dose equivalent, committed dose equivalent, committed effective dose equivalent, total organ dose equivalent, or total effective dose equivalent. For purposes of these regulations, "radiation dose" is an equivalent term.

  • Marijuana product means marijuana as defined in 50-32-101 and marijuana-infused products